User profiles for "author:Irene Lara-Corrales"

Irene Lara-Corrales

Associate Professor of Pediatrics
Verified email at sickkids.ca
Cited by 3312

Mosaic neurofibromatosis type 1: a systematic review

MT García‐Romero, P Parkin… - Pediatric …, 2016 - Wiley Online Library
Confusion is widespread regarding segmental or mosaic neurofibromatosis type 1 (MNF 1).
Physicians should use the same terms and be aware of its comorbidities and risks. The …

Hidradenitis suppurativa in the pediatric population

C Liy-Wong, E Pope, I Lara-Corrales - Journal of the American Academy of …, 2015 - Elsevier
Hidradenitis suppurativa (HS) generally appears after puberty, is infrequently seen in
younger children, and early onset, which is associated with more widespread disease, is …

The collagenopathies: review of clinical phenotypes and molecular correlations

R Jobling, R D'Souza, N Baker, I Lara-Corrales… - Current rheumatology …, 2014 - Springer
Genetic defects of collagen formation (the collagenopathies) affect almost every organ
system and tissue in the body. They can be grouped by clinical phenotype, which usually …

“Eczema coxsackium” and unusual cutaneous findings in an enterovirus outbreak

EF Mathes, V Oza, IJ Frieden, KM Cordoro, S Yagi… - …, 2013 - publications.aap.org
OBJECTIVE: To characterize the atypical cutaneous presentations in the coxsackievirus A6
(CVA6)–associated North American enterovirus outbreak of 2011–2012. METHODS: We …

A consensus approach to wound care in epidermolysis bullosa

E Pope, I Lara-Corrales, J Mellerio, A Martinez… - Journal of the American …, 2012 - Elsevier
BACKGROUND: Wound care is the cornerstone of treatment for patients with epidermolysis
bullosa (EB); however, there are currently no guidelines to help practitioners care for these …

Timolol maleate 0.5% or 0.1% gel‐forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study

A Chakkittakandiyil, R Phillips, IJ Frieden… - Pediatric …, 2012 - Wiley Online Library
Therapeutic options for superficial infantile hemangiomas (IH) are limited. Recently, timolol
maleate gel, a topical nonselective beta‐blocker, has been reported as a potentially effective …

[HTML][HTML] Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease

WHA Kahr, FG Pluthero, A Elkadri, N Warner… - Nature …, 2017 - nature.com
Abstract Human actin-related protein 2/3 complex (Arp2/3), required for actin filament
branching, has two ARPC1 component isoforms, with ARPC1B prominently expressed in …

Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: the PeDRA TREAT survey

CR Totri, LF Eichenfield, K Logan, L Proudfoot… - Journal of the American …, 2017 - Elsevier
Background There is a paucity of literature to direct physicians in the prescribing of
immunomodulators for patients with severe atopic dermatitis (AD). Objective To survey …

Safety of systemic agents for the treatment of pediatric psoriasis

IMGJ Bronckers, MMB Seyger, DP West… - JAMA …, 2017 - jamanetwork.com
Importance Use of systemic therapies for moderate to severe psoriasis in children is
increasing, but comparative data on their use and toxicities are limited. Objective To assess …

Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients

C Liy-Wong, M Kim, AY Kirkorian… - JAMA …, 2021 - jamanetwork.com
Importance Hidradenitis suppurativa (HS) in pediatric patients has been understudied.
Increased awareness and recognition of HS prevalence in children demand efforts to better …